High Dose NAD+ Patches

Offered by Ion Layer

Ion Layer’s NAD+ Patches are high-dose, needle-free transdermal patches designed as an alternative to IV infusions. Each patch delivers 500 mg of NAD+ directly into the bloodstream over ~14 hours using iontophoresis technology. A full kit includes 6 patches plus the supplies needed to activate and apply them. There’s a 30-day money-back guarantee, and the product requires a prescription through a short intake form.

Overview

The NAD+ Patches are medical-grade patches that deliver nicotinamide adenine dinucleotide (NAD+) through the skin using iontophoresis (a mild electrical current). This method bypasses the digestive system, aiming for faster/stabler absorption. They are intended to mimic the effects of IV NAD+ infusions, but more conveniently, from home.

What’s Included in the Kit

  • 6 transdermal patches
  • 6 vials of 500 mg NAD+ powder (to be mixed before application)
  • 6 protective adhesive covers
  • 6 sterile solution tubes (for mixing)
  • 6 saline solution tubes (for applying from the patch’s negative side)

Usage Protocol

  • A 30-day protocol is suggested: 1 patch every 5 days (i.e. 6 patches in total)
  • You wear each patch for 12-14 hours on clean, hair-free skin.
  • Patches are prepared by mixing the NAD+ powder with the sterile solution, activating the patch, then applying it.
  • Replace the patch every fifth day for the 30-day protocol.

Benefits & Claims

  • Boost energy, metabolism, and mitochondrial function
  • Reduce inflammation and speed recovery
  • Support cognitive sharpen-up and overall cellular health
  • Potentially improve physical performance and longevity
  • Delivered more affordably than traditional NAD+ IV infusions

Safety, Requirements & Guarantees

  • Because the product is classified as a class-2 medical device, a prescription is required; Ion Layer collects an intake form + ID after purchase.
  • There's a 30-day money-back guarantee for first-time buyers.
  • The patches are intended to be safe: minimal side effects expected; skin sensitivity is the primary risk.

Provider details

Ion LayerVisit provider website